Behavioral
Clearfield Hospital (Dba Penn Highlands Clearfield Eff 7/01/14)
Clearfield Hospital (Dba Penn Highlands Clearfield Eff 7/01/14) was paid $409K by Medicaid between Jul 2021 and Jan 2023, across 103 billing codes. Its largest line is G0299, Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes — 19% of everything it billed.
33Billing provider infoCLEARFIELD HOSPITAL (DBA PENN HIGHLANDS CLEARFIELD EFF 7/01/14)
CLEARFIELD, PA 16830
CLEARFIELD, PA 16830
33aNPI1740604776assigned 02/11/2014
33bProvider typeProfessional Counselor
28Total paid$409K
24GClaims12,790
24DCodes billed103
24AFirst – last monthJul 2021 – Jan 2023
Compared with peers
Next to other Professional Counselor providers in Pennsylvania
Rank by total paid#33 of 414
Median peer was paid$61K
This provider vs. median6.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 10,912 | $360K | |
| 2022 | 1,831 | $44K | |
| 2023 | 47 | $5K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0299 | Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes | 19% | 755 | 197 | $78K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 840 | 816 | $68K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 455 | 435 | $55K |
| G0378 | Hospital observation service, per hour | 6.7% | 12 | 12 | $28K |
| 87631 | 6.2% | 167 | 165 | $25K | |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 4.5% | 372 | 116 | $18K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.3% | 119 | 111 | $18K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.5% | 122 | 121 | $10K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.9% | 271 | 267 | $8K |
| 80053 | Comprehensive metabolic panel | 1.8% | 671 | 617 | $7K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.6% | 41 | 38 | $6K |
| 80050 | General health panel | 1.3% | 119 | 115 | $6K |
91 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 872 | $5K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.1% | 112 | $4K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.0% | 110 | $4K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 139 | $4K |
| 80061 | Lipid panel | <1% | 269 | $4K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 37 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 121 | $3K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 15 | $3K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 29 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 236 | $2K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 27 | $2K |
| 86618 | <1% | 74 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 71 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 71 | $2K |
| 83735 | <1% | 280 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 193 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 107 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 97 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 162 | $1K |
| 84484 | <1% | 167 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 186 | $1K |
| 71045 | Radiologic examination, chest; single view | <1% | 184 | $1K |
| 84439 | <1% | 140 | $1K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 18 | $1K |
| 83880 | <1% | 37 | $1K | |
| 81001 | <1% | 327 | $960.30 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 80 | $922.02 |
| 87081 | <1% | 155 | $869.44 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 57 | $841.50 |
| 82728 | <1% | 66 | $805.20 | |
| 83721 | <1% | 63 | $805.20 | |
| 87077 | <1% | 91 | $773.19 | |
| 85027 | <1% | 104 | $760.84 | |
| 86617 | <1% | 16 | $753.28 | |
| 73630 | <1% | 60 | $733.70 | |
| 87480 | <1% | 28 | $699.72 | |
| 87660 | <1% | 28 | $690.48 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 563 | $679.40 |
| 82607 | <1% | 51 | $672.10 | |
| 84702 | <1% | 39 | $632.10 | |
| 87186 | <1% | 66 | $589.60 | |
| 82043 | <1% | 69 | $554.40 | |
| 83690 | <1% | 116 | $550.00 | |
| 86038 | <1% | 34 | $511.50 | |
| 82570 | <1% | 71 | $503.68 | |
| 73610 | <1% | 28 | $494.40 | |
| 85610 | <1% | 136 | $462.00 | |
| 80076 | <1% | 50 | $446.85 | |
| 87040 | <1% | 24 | $446.60 | |
| 85730 | <1% | 83 | $445.50 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 12 | $408.16 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 12 | $390.12 |
| 84153 | <1% | 16 | $375.20 | |
| 90715 | <1% | 12 | $333.15 | |
| 73130 | <1% | 26 | $328.90 | |
| 72110 | <1% | 16 | $321.75 | |
| 83605 | <1% | 46 | $299.20 | |
| 84481 | <1% | 12 | $283.25 | |
| 87510 | <1% | 28 | $282.24 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 721 | $275.70 |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 13 | $271.70 |
| 73564 | <1% | 17 | $271.26 | |
| 83540 | <1% | 32 | $269.70 | |
| 82784 | <1% | 13 | $268.66 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 15 | $259.38 |
| 84703 | <1% | 25 | $248.38 | |
| 85379 | <1% | 32 | $244.86 | |
| 85652 | <1% | 70 | $214.50 | |
| 82746 | <1% | 16 | $211.20 | |
| 84460 | <1% | 27 | $205.92 | |
| 84450 | <1% | 27 | $203.84 | |
| 86140 | <1% | 64 | $188.10 | |
| 84550 | <1% | 29 | $185.22 | |
| 81025 | <1% | 41 | $180.40 | |
| 84100 | <1% | 29 | $144.20 | |
| 82150 | <1% | 27 | $126.50 | |
| 73110 | <1% | 14 | $126.50 | |
| 86431 | <1% | 15 | $119.00 | |
| 82565 | <1% | 16 | $112.80 | |
| 81003 | <1% | 34 | $109.12 | |
| 83615 | <1% | 13 | $94.92 | |
| 83550 | <1% | 15 | $77.00 | |
| 86592 | <1% | 15 | $66.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 74 | $47.88 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 18 | $34.68 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 490 | $33.27 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 413 | $21.96 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 34 | $20.76 |
| 36415 | Collection of venous blood by venipuncture | 0% | 37 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 13 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 108 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCAIN, BILL (CFO)
Parent organizationCLEARFIELD HOSPITAL